Should I invest in UTI - TOP 100 Fund?

We don't give personal investment advice. UTI - TOP 100 Fund- Growth Option is suitable for an investor whose:time horizon is **5+ years** — equity funds can drop 30-50% in bad years; horizons under 5 years materially raise the risk of selling at a lossrisk tolerance accepts seeing the portfolio fall sharply without panic-sellinggoal isn't capital preservation in the short termCross-check the numbers above against alternatives before deciding. Worst 5-year drawdown: 18.6%. 5-year CAGR: 15.34%.

UTI

UTI - TOP 100 Fund- Growth Option

Unit split applied to historical metrics

This scheme had a 0.5× unit consolidation on 5 Jun 2009. Returns, SIP simulations and risk metrics on this page are split-adjusted — they reflect what a real investor's portfolio experienced (a consolidation doesn't change portfolio value, only the unit count and per-unit NAV).

Latest NAV

₹177.6776

As of

3 Jun 2026

4,955 NAV records on file

NAV history & peer comparison

All NAVs split-adjusted and normalised to 100 at the start of the selected period, so funds with very different absolute NAV scales can be compared on one axis.

Period

Add another fund to compare

No matches.

Compares up to 8 funds. Click any line in the legend above to hide/show it.

Returns matrix

Fund return alongside the category average and peer rank for every standard window. Returns under one year are absolute; one year and longer are compound annualised (CAGR).

Window	Fund	Category avg	+/− vs avg	Rank	Quartile
1D	+0.38%	+0.11%	+0.26	6 / 32	Q1
1W	-1.77%	-1.76%	-0.01	15 / 32	Q2
2W	-1.01%	-0.27%	-0.74	23 / 32	Q3
1M	-1.55%	-1.02%	-0.53	20 / 32	Q3
3M	-1.41%	-1.18%	-0.23	13 / 32	Q2
6M	-4.11%	-5.43%	+1.31	12 / 32	Q2
YTD	-5.32%	-5.57%	+0.24	19 / 32	Q3
1Y	+2.18%	-1.21%	+3.40	10 / 32	Q2
2Y	+5.88%	+1.22%	+4.66	6 / 32	Q1
3Y	+18.45%	+13.45%	+4.99	4 / 32	Q1
4Y	+18.13%	+13.62%	+4.50	4 / 32	Q1
5Y	+15.34%	+11.89%	+3.45	8 / 32	Q1
7Y	+16.02%	+12.99%	+3.03	8 / 32	Q1
10Y	+13.94%	+11.48%	+2.46	11 / 32	Q2
Inception	+11.35%	+9.20%	+2.15	14 / 29	Q2

Quartile legend: Q1 top 25% Q2 25-50% Q3 50-75% Q4 bottom 25%

Calendar-year returns

Full-year performance vs category average. Current year is partial (year-to-date).

Year	Fund	Category avg	+/− vs avg	Rank
2026 YTD	-5.32%	-5.57%	+0.24	19 / 32
2025	+7.07%	+2.91%	+4.17	5 / 32
2024	+26.61%	+19.92%	+6.69	5 / 32
2023	+34.29%	+27.73%	+6.56	4 / 32
2022	+4.58%	+2.49%	+2.08	14 / 32
2021	+39.64%	+32.49%	+7.16	4 / 32
2020	+12.43%	+13.97%	-1.54	20 / 32
2019	+1.32%	+4.84%	-3.51	25 / 32
2018	-7.77%	-10.87%	+3.10	11 / 32
2017	+34.45%	+31.34%	+3.10	13 / 32
2016	+2.94%	+2.52%	+0.41	17 / 32

Rolling returns

Removes start-date bias by averaging CAGR over every overlapping N-year window in the fund's history. Higher average plus tight min/max plus high "% positive" = consistent.

1-Year rolling

+14.88%

234 windows

min -55.5% · max 94.2%

77% positive

3-Year rolling

+12.51%

210 windows

min -10.1% · max 32.4%

93% positive

5-Year rolling

+12.26%

185 windows

min -4.5% · max 29.6%

97% positive

7-Year rolling

+11.73%

161 windows

min 4.3% · max 18.4%

100% positive

SIP returns — historical "what if"

If you had invested every month in this fund over the chosen period, this is what your investment would be worth today.

Period

Total invested

₹ —

Today's value

₹ —

XIRR

Annualised

Wealth multiplier

Period	Total invested	Today's value	XIRR	Wealth multiplier

XIRR is the annualised internal rate of return on the SIP cash flow — invariant to the monthly amount. "Today's value" and "Total invested" scale linearly with the slider. Past performance does not guarantee future returns. Excludes exit load and taxes.

Risk profile

Risk-adjusted return and volatility, computed from monthly NAV returns over the trailing 3-year and 5-year windows.

Std deviation

13.73%

3-year · annualised

Sharpe ratio

0.84

vs risk-free 6.5%

Sortino ratio

1.37

Downside-only deviation

Max drawdown

-17.86%

Sep 2024 → Feb 2025

% positive months

75.0%

Share of monthly returns > 0 over the 3-year window

Sharpe / Sortino use a risk-free rate of 6.5% (1-year T-bill proxy). Higher Sharpe = more return per unit of total risk; higher Sortino = more return per unit of downside risk.

Peers in Large & Mid Cap Fund

Scheme	Fund house	NAV	As of
HDFC Large and Mid Cap Fund - Growth Option	HDFC	₹329.5320	3 Jun 2026
SBI Magnum Multiplier Plus Scheme - 93 -Dividend	SBI	₹282.7709	2 Jun 2026
ICICI Prudential Growth Plan-Dividend Option	ICICI Prudential	₹28.9300	3 Jun 2026
Franklin India Flexi Cap Fund-Dividend Plan	Franklin Templeton	₹18.7310	3 Jun 2026
Kotak Opportunities---Dividend	Kotak Mahindra	₹58.2030	3 Jun 2026
Canara Robeco Emerging Equities-GROWTH PLAN	Canara Robeco	₹239.5300	3 Jun 2026
UTI - TOP 100 Fund-Income Option	UTI	₹86.5568	3 Jun 2026
Bharti AXA Equity Fund Eco Plan- Growth	Bharti AXA	₹97.8700	3 Jun 2026
Birla Sun Life Advantage Fund-Plan A (Dividend)	Birla Sun Life	₹129.9500	3 Jun 2026
Escorts High Yield Equity Plan - Dividend Option	Escorts	₹74.2930	3 Jun 2026

Recent NAVs

Date	NAV
3 Jun 2026	₹177.6776
2 Jun 2026	₹178.6855
1 Jun 2026	₹178.0166
29 May 2026	₹179.3021
27 May 2026	₹181.7253
26 May 2026	₹181.9010
25 May 2026	₹181.9716
22 May 2026	₹180.2556
21 May 2026	₹180.5394
20 May 2026	₹180.4909

Frequently asked questions

These answers are generated from this fund's live metrics — NAV, returns, peer rank, drawdown, SIP backtest. Numbers refresh nightly after AMFI's NAV feed lands.

As of 03 Jun 2026, the NAV of UTI - TOP 100 Fund- Growth Option is ₹177.6776. It's a Large & Mid Cap Fund from UTI, run as a Unknown plan Growth option. NAVs update once per business day from the AMFI feed.

UTI - TOP 100 Fund- Growth Option has NAV history starting from 03 Apr 2006, a track record of about 20 years 2 months. Long-tenured funds like this have weathered multiple market cycles — the 2008 crash, 2013 taper tantrum, 2020 COVID drawdown — which makes their returns more credible than a 3-year track record alone.

UTI - TOP 100 Fund- Growth Option is managed by UTI. It's classified by AMFI under the 'Large & Mid Cap Fund' SEBI category, which determines its peer set and tax treatment.

Over the trailing 1-year window, UTI - TOP 100 Fund- Growth Option has delivered a absolute return of 2.18% — +3.4 pp ahead of the Large & Mid Cap Fund category average of -1.21%. The fund ranks #10 of 32 in its category — the second (Q2) quartile.

Over the trailing 3-year window, UTI - TOP 100 Fund- Growth Option has delivered a CAGR of 18.45% — +4.99 pp ahead of the Large & Mid Cap Fund category average of 13.45%. The fund ranks #4 of 32 in its category — the top (Q1) quartile.

Over the trailing 5-year window, UTI - TOP 100 Fund- Growth Option has delivered a CAGR of 15.34% — +3.45 pp ahead of the Large & Mid Cap Fund category average of 11.89%. The fund ranks #8 of 32 in its category — the top (Q1) quartile.

₹1 lakh invested in UTI - TOP 100 Fund- Growth Option exactly 10 years ago would be worth approximately ₹368,623 today — a multiplier of 3.69×, based on the 10-year CAGR of 13.94%. The category average over the same window would have grown ₹1 lakh to ₹296,438.

A ₹10,000 monthly SIP in UTI - TOP 100 Fund- Growth Option over the last 5 years — total invested ₹600,000 — would be worth ₹850,430 today. That's an XIRR (money-weighted annualised return) of 13.91%.

A ₹10,000 monthly SIP for 10 years in UTI - TOP 100 Fund- Growth Option = ₹1,200,000 invested. It would currently be worth ₹2,672,095 (multiplier 2.23×). XIRR: 15.29%. Long-horizon SIP results matter more than point-to-point returns because they smooth out entry timing.

On a 5-year basis, UTI - TOP 100 Fund- Growth Option ranks #8 out of 32 funds in the Large & Mid Cap Fund category — that places it in the top quartile (Q1) — strong outperformance. The category average return over the same window is 11.89%; this fund delivered 15.34%.

The worst peak-to-trough decline UTI - TOP 100 Fund- Growth Option has experienced over the last 5-year window is 18.63% — its NAV fell from a high on 18 Oct 2021 to a low on 20 Jun 2022. Drawdown is a useful gauge of how much short-term pain you'd have endured to capture the long-term return.

Across all 5-year rolling windows, UTI - TOP 100 Fund- Growth Option averaged 12.26% (best 29.58%, worst -4.50%). 97% of rolling windows ended positive. The 5-year Sharpe ratio is 0.65 — reasonable risk-adjusted performance.

In calendar year 2025, UTI - TOP 100 Fund- Growth Option returned 7.07% — beating the Large & Mid Cap Fund category average of 2.91% by 4.17 pp. It ranked #5 of 32 in its category that year.

UTI - TOP 100 Fund- Growth Option is classified as an Equity fund (at least 65% equity exposure). Tax rules (post Budget 2024): if you hold 12 months or more, gains are Long-Term and taxed at 12.5% on the amount exceeding ₹1.25 lakh per financial year. Held for under 12 months, gains are Short-Term and taxed at 20%. The ₹1.25 L exemption is per PAN per FY across all equity LTCG.

We don't give personal investment advice. UTI - TOP 100 Fund- Growth Option is suitable for an investor whose:

time horizon is **5+ years** — equity funds can drop 30-50% in bad years; horizons under 5 years materially raise the risk of selling at a loss
risk tolerance accepts seeing the portfolio fall sharply without panic-selling
goal isn't capital preservation in the short term

Cross-check the numbers above against alternatives before deciding. Worst 5-year drawdown: 18.6%. 5-year CAGR: 15.34%.

Educational content only — not investment advice. Tax rules summarised above reflect Budget 2024; consult a qualified adviser before transacting.